Search hospitals > Kansas > Wellington

Cancer Center of Kansas - Wellington

Claim this profile
Wellington, Kansas 67152
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
396 reported clinical trials
2 medical researchers
Photo of Cancer Center of Kansas - Wellington in WellingtonPhoto of Cancer Center of Kansas - Wellington in WellingtonPhoto of Cancer Center of Kansas - Wellington in Wellington

Summary

Cancer Center of Kansas - Wellington is a medical facility located in Wellington, Kansas. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Cancer Center of Kansas - Wellington is involved with conducting 396 clinical trials across 450 conditions. There are 2 research doctors associated with this hospital, such as Shaker Dakhil, M.D. and Dennis F. Moore.

Area of expertise

1Cancer
Global Leader
Cancer Center of Kansas - Wellington has run 88 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Breast Cancer
Global Leader
Cancer Center of Kansas - Wellington has run 82 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
HER2 positive

Top PIs

Clinical Trials running at Cancer Center of Kansas - Wellington

Breast Cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Lung Cancer
Bladder Cancer
Renal Cell Carcinoma
Follicular Lymphoma
Cancer
Colorectal Cancer
Squamous Cell Carcinoma
Image of trial facility.

Shorter Chemo-Immunotherapy Without Anthracyclines

for Breast Cancer

This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Image of trial facility.

Support Program

for Breast Cancer

This study is evaluating whether a support program may help breast cancer patients take their medication correctly.
Recruiting2 awards Phase 34 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Cancer Center of Kansas - Wellington?
Cancer Center of Kansas - Wellington is a medical facility located in Wellington, Kansas. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Cancer Center of Kansas - Wellington is involved with conducting 396 clinical trials across 450 conditions. There are 2 research doctors associated with this hospital, such as Shaker Dakhil, M.D. and Dennis F. Moore.
Where is Cancer Center of Kansas - Wellington located?
The Cancer Center of Kansas in Wellington is located at 507 E 16th St, Wellington, KS 67152.
Who should I call to ask about financial aid or insurance network?
**Cancer Center of Kansas - Wellington Financial Assistance Information:** - For financial and insurance inquiries, contact the Patient Financial Service Department at (866) 772-6309 or (561) 798-8678, Monday to Friday, 8:30 a.m. - 4:30 p.m. - Patient Assistance Counselors are available to help eligible patients secure financial assistance for cancer treatment costs. They collaborate with drug manufacturers, foundations, and local oncology societies to provide copay assistance or grants. - Eligibility for assistance varies, often requiring proof of income and signed forms. Additional resources are available through Ascension Medical Group Via Christi in Wellington for cancer patients.
What insurance does Cancer Center of Kansas - Wellington accept?
The Cancer Center of Kansas (CCK) accepts Medicare, most major insurance carriers, Medicaid for Kansas, Missouri, and Oklahoma, and provides services to uninsured individuals. Ensure you have a referral from your primary care physician if your insurance requires one before your appointment. The CCK Business Office handles billing, coordinates payments, communicates with insurance companies for proper payment, obtains prior authorizations and necessary referrals, facilitates patient assistance, and ensures patients receive maximum benefits from their insurance plans.
What awards or recognition has Cancer Center of Kansas - Wellington received?
The Cancer Center of Kansas - Wellington has been awarded the Kansas Health Information Networks Certificate of Achievement and named the Wichita Kansas Reader's Choice Favorite Cancer Center in 2016 and 2018. It has been recognized as a 2016 Admirable Statewide Partner for its outstanding dedication. The center participates in clinical trials recognized by leading institutions, including the National Cancer Institute, Southwest Oncology Group, and Memorial Sloan Kettering Cancer Center.